Antonia Gantschnigg

Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Jakob M. Riedl, Florian Posch, Lena Horvath et al. · European Journal of Cancer · 2021 · 58 citations · Full text

Medicine, Oncology, Pharmacology +9

Short-term outcomes and costs analysis of robotic-assisted versus laparoscopic cholecystectomy—a retrospective single-center analysis

Antonia Gantschnigg, Oliver O. Koch, Franz Singhartinger et al. · Langenbeck s Archives of Surgery · 2023 · 24 citations · Full text

Medicine, Perioperative Medicine, Surgery +15

A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts

Laura Bravo, Joana F F Simoes, Victor Roth Cardoso et al. · The Lancet Digital Health · 2024 · 20 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Robotic surgery versus conventional laparoscopy in sigmoid colectomy for diverticular disease-a comparison of operative trauma and cost-effectiveness: retrospective, single-center analysis

J Presl, M. Ehgartner, L. Schabl et al. · Langenbeck s Archives of Surgery · 2024 · 16 citations · Full text

Medicine, Surgery, Bowel Management +16

Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel

Jakob M. Riedl, Esther Schwarzenbacher, Florian Moik et al. · Thrombosis and Haemostasis · 2021 · 14 citations

Medicine, Oncology, Pharmacology +17